Facebook Linkedin Mail X Youtube
  • Home
  • Latest News
  • Features
  • Structural Heart
  • Profiles
  • Videos
  • Events
  • Supplements
  • Past Issues
  • Subscribe
Search
Facebook Linkedin Mail X Youtube
Cardiovascular News Cardiovascular News
Cardiovascular News Cardiovascular News
  • Home
  • Latest News
  • Features
  • Structural Heart
  • Profiles
  • Videos
  • Events
  • Supplements
  • Past Issues
  • Subscribe

Tag: Spyral

Attention turns to multi-organ denervation as new evidence supports “durability” of blood pressure reductions

22nd November 2024
New research will inv...

AHA 2022: SPYRAL HTN-ON MED study demonstrates “meaningful clinical benefits” consistent with other renal denervation trials

8th November 2022
Medtronic has announc...

EuroPCR 2022: Sham controlled trials have “revitalised” interest in renal denervation

19th May 2022
 “Renal denervation h...

US FDA approve new study of Medtronic’s Spyral renal denervation system

12th November 2018
The FDA have given Me...

EuroPCR 2018: Positive data for renal denervation reignites interest in field

23rd May 2018
After two studies ind...

New trial of Symplicity Spyral approved

13th April 2018
Medtronic has announc...
Cardiovascular News

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com


BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy
Facebook Linkedin Mail X Youtube